metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Effect of the combination of orlistat and l-carnitine on the quality of life (sf...
Información de la revista
Vol. 29. Núm. S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(febrero 2024)
Acceso a texto completo
Effect of the combination of orlistat and l-carnitine on the quality of life (sf-36) in 16 overweigth patients. a preliminary result
Visitas
990
Saúl A. Vera-Nungaray1, Miguel Y. Carmona-Castillo1, María F. Higuera-de la Tijera1, Livan Delgado-Roche2, Evelyn Altamirano-Castillo3, Nancy G. Vega-López4, Uriel Gutiérrez-Estrada4, Santiago Camacho-Hernández1
1 Gastroenterology Service, General Hospital of Mexico, Mexico City, Mexico
2 Clinical Research Manager, Liomont Laboratories, Mexico City, Mexico City, Mexico
3 General Hospital Of Zone 8, Mexican Social Security Institute, Mexico City, Mexico
4 National Polytechnic Institute, Mexico City, Mexico
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S2

Abstracts Asociación Mexicana del Hígado (AMH) 2023

Más datos
Introduction and Objectives

Orlistat is a drug widely used in overweight/obese patients, while the combination with l-carnitine could offer an improvement in its effectiveness. To our knowledge, the effect of this combination on the quality of life of overweight patients has not been determined.

To evaluate the effects on the quality of life of patients who took the combination of orlistat and l-carnitine at 4 and 8 weeks of treatment.

Materials and Patients

: We evaluated the quality of life (Short Form-36) in 16 patients [41.81±8.26 (37.77-45.86) years, 81% women] undergoing pharmacotherapy of the combination of orlistat and l-carnitine (once a day) at 4 and 8 weeks of treatment. Data express mean±SD and 95%IC or percentages as correspond. We use paired Student t Test, two tails with an alpha=0.05.

Results

Patients lowered their weight by about 3%. Patients show improvement in body pain, general health, vitality and in both Mental [45.68±6.51 (42.49-48.86) vs. 49.88±3.21 (48.31-51.46), p=0.02] and Physical [59.4±8.92 (55.03-63.77) vs. 63.36±9.64 (58.63-68.08), p=0.01) summaries.

Conclusions

These results suggest a beneficial effect of the combination of Orlistat and l-carnitine on the treatment of overweight. Further studies compared with placebo and standard care are required.

Texto completo

Ethical statement

The protocol was approved by the local research and ethical committees.

Registration number: DECS/JPO-CT-1944-2023.

Declaration of interests

None

Funding

Laboratorios Liomont provided the medicament “orlistat and l-carnitine” for this study.

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2024.101436
No mostrar más